| | | | | | | | | | |
|
|
| Dockets Entered
On November 29, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
| 2003P-0531
|
| Issue a report providing the necessary information on pill weight tolerances and/or variations caused by reformulations
|
|
|
| 2004D-0453
|
| Compliance Policy Guide Sec. 560.400 - 'Imported Milk and Cream Federal Import Milk Act (CPG 7119.05)'
|
|
|
| 2005D-0312
|
| Guidance for Industry on ANDAs: Impurities in Drug Products; Chemistry, Manufacturing, and Controls Information; Availability
|
|
|
| 2005D-0385
|
| Guidance for Industry on Using Electronic Means to Distribute Certain Product Information
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005N-0311
|
| Critical Path Initiative; Developing Prevention Therapies; Planning of Workshop
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
| 2005P-0221
|
| amend the regulations governing the labeling of milk products in Part 131 of the Title 21 of the Code of Federal Regulations
|
|
|
| 2005P-0436
|
| ADA 21-863' Ibuprogen Liquid filled gelatin capsules 200 mg; Ranbaxy Laboratories, Ltd.
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
16977
|
| NDS Nutritiion, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16978
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16979
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16980
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16981
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16982
|
| NDS Nutrtion, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16983
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16984
|
| Enzymatic Therapy
|
| Vol #:
|
| 153
|
|
|
| LET 16985
|
| NDS Nutrition, LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16986
|
| The Procter and Gamble Company
|
| Vol #:
|
| 153
|
|
|
| LET
16987
|
| Mindkeepers, Inc.
|
| Vol #:
|
| 153
|
|
|
| LET
16988
|
| Hillestad Pharmaceutical
|
| Vol #:
|
| 153
|
|
|
| LET
16989
|
| Hillestad Pharmaceutical
|
| Vol #:
|
| 153
|
|
|
| LET
16990
|
| New Chapter, Inc.
|
| Vol #:
|
| 153
|
|
|
| LET
16991
|
| New Chapter, Inc.
|
| Vol #:
|
| 153
|
|
|
| LET
16992
|
| Pharmavite LLC
|
| Vol #:
|
| 153
|
|
|
| LET
16993
|
| DMD Pharmaceuticals
|
| Vol #:
|
| 153
|
|
|
| LET
16994
|
| DMD Pharmaceuticals
|
| Vol #:
|
| 153
|
|
|
| LET
16995
|
| Millennium Biotechnologies, Inc.
|
| Vol #:
|
| 153
|
|
|
| LET
16996
|
| Enzymatic Therapy
|
| Vol #:
|
| 153
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
| C 220
|
| W. Bagley
|
| Vol #:
|
| 24
|
|
|
| C 221
|
| H. Bietry
|
| Vol #:
|
| 24
|
|
| | | | | | | |
|
|
| C 222
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 223
|
| M. Londo
|
| Vol #:
|
| 24
|
|
|
| C 224
|
| S. Ng
|
| Vol #:
|
| 24
|
|
|
| C 225
|
| S. Hoyt
|
| Vol #:
|
| 24
|
|
|
| C 226
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 227
|
| J. Fuentes
|
| Vol #:
|
| 24
|
|
|
| C 228
|
| W. Cruz
|
| Vol #:
|
| 24
|
|
|
| C 229
|
| J. Ramirez
|
| Vol #:
|
| 24
|
|
|
| C 230
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 231
|
| R. Soria
|
| Vol #:
|
| 24
|
|
|
| C 232
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 233
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 234
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 235
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 236
|
| M. Lewis
|
| Vol #:
|
| 24
|
|
|
| C 237
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 238
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 239
|
| Eligible
|
| Vol #:
|
| 24
|
|
|
| C 240
|
| M. Renesa
|
| Vol #:
|
| 24
|
|
|
| C 241
|
| A. Cordova
|
| Vol #:
|
| 24
|
|
|
| C 242
|
| N. Nagel
|
| Vol #:
|
| 24
|
|
|
| C 243
|
| C. Beiler
|
| Vol #:
|
| 24
|
|
|
| C 244
|
| R. Martin
|
| Vol #:
|
| 24
|
|
|
| C 245
|
| F. Martin
|
| Vol #:
|
| 24
|
|
|
| C
246
|
| Valley Proteins, Inc.
|
| Vol #:
|
| 24
|
|
|
| C 247
|
| C. Esh
|
| Vol #:
|
| 24
|
|
|
| C 248
|
| D. Stotgfer
|
| Vol #:
|
| 24
|
|
|
| C 249
|
| M. McElwain
|
| Vol #:
|
| 24
|
|
|
| C 250
|
| N. Muller
|
| Vol #:
|
| 24
|
|
|
| C 251
|
| T. Embry
|
| Vol #:
|
| 27
|
|
|
| C 252
|
| M. Bulleri
|
| Vol #:
|
| 27
|
|
|
| C 253
|
| K. Zeigler
|
| Vol #:
|
| 27
|
|
|
| C 254
|
| T. Enriquez
|
| Vol #:
|
| 24
|
|
|
| C 255
|
| T. Thompson
|
| Vol #:
|
| 27
|
|
|
| C 256
|
| M. Dillon
|
| Vol #:
|
| 27
|
|
|
| C 257
|
| D. Sarber
|
| Vol #:
|
| 27
|
|
|
| C 258
|
| J. Carr
|
| Vol #:
|
| 27
|
|
| | | | | | | | |
|
|
| 2003P-0531
|
| Issue a report providing the necessary information on pill weight tolerances and/or variations caused by reformulations
|
|
|
| LET
3
|
| Fulcrum Inc.
|
| Vol #:
|
| 1
|
|
|
| LET
4
|
| HFD-240 to Fulcrum Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004D-0453
|
| Compliance Policy Guide Sec. 560.400 - 'Imported Milk and Cream Federal Import Milk Act (CPG 7119.05)'
|
|
|
| C 8
|
| J. Lamp
|
| Vol #:
|
| 1
|
|
|
| C 9
|
| R and K Breneman
|
| Vol #:
|
| 1
|
|
|
| 2005D-0312
|
| Guidance for Industry on ANDAs: Impurities in Drug Products; Chemistry, Manufacturing, and Controls Information; Availability
|
|
|
| C
3
|
| Sandoz GmbH
|
| Vol #:
|
| 1
|
|
|
| 2005D-0385
|
| Guidance for Industry on Using Electronic Means to Distribute Certain Product Information
|
|
|
| C
1
|
| Abbott
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| MO 4
|
| GCF-1, TMJ Implants, Inc. and Robert W. Christensen and Maureen K . Mooney
|
| Vol #:
|
| 1
|
|
|
| RMO 1
|
| TMJ Implants, Inc, and Robert W. Christensen, and Maureen K Mooney
|
| Vol #:
|
| 1
|
|
|
| 2005N-0311
|
| Critical Path Initiative; Developing Prevention Therapies; Planning of Workshop
|
|
|
| C
4
|
| Novartis Pharmaceuticals Corporation (Novartis)
|
| Vol #:
|
| 1
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
| C 9
|
| T. Kralj
|
| Vol #:
|
| 2
|
|
|
| 2005P-0221
|
| amend the regulations governing the labeling of milk products in Part 131 of the Title 21 of the Code of Federal Regulations
|
|
|
| LET
1
|
| HFS-800 to City of Allentown Health Bureau
|
| Vol #:
|
| 1
|
|
|
| 2005P-0436
|
| ADA 21-863' Ibuprogen Liquid filled gelatin capsules 200 mg; Ranbaxy Laboratories, Ltd.
|
|
|
| AMD
1
|
| Banner Pharmacaps Inc.
|
| Vol #:
|
| 1
|
|
|